Back to company

Symbiotiq ApS: Financial statements 2025

CVR: 42741809

Symbiotiq ApS (CVR 42741809) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,352,873 and a net result of DKK 288,354 compared with DKK 585,824 the year before. That is an increase of 27.6% compared with the year before. Equity amounted to DKK 2,077,864. The solvency ratio was 61.5%.

Gross Profit
1,352,873 kr.
Profit/Loss
288,354 kr.
Equity
2,077,864 kr.
Total Assets
3,379,698 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-1.4 mio.288 t.2.1 mio.0
2024-1.1 mio.586 t.1.9 mio.-
2023-1.5 mio.898 t.1.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Symbiotiq ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Symbiotiq ApS: The 2024 annual report is outFeb 5, 2025

Symbiotiq ApS has published its annual report for 2024. Gross profit came to DKK 1,060,359, and the net result was DKK 585,824.

About Symbiotiq ApS

Symbiotiq ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Bonde. The company is owned by Mads Bonde. In 2025, the company reported a gross profit of DKK 1,352,873 and a net result of DKK 288,354 compared with DKK 585,824 the year before. Equity amounted to DKK 2,077,864.

Other financial years